Skip to content

Effect of eight weeks of green tea supplementation on cardiovascular risk factors in overweight individuals

Changes in cardiovascular risk factors of overweight men after eight weeks supplementation of green tea and weight training

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013080414267N1
Enrollment
30
Registered
2014-01-20
Start date
2013-04-09
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular disease. Atherosclerotic cardiovascular disease

Interventions

Intervention 1: Intervention group 1: Weight training and supplementation with green tea: 10 subjects did weight training for 8 weeks, 3 sessions per week, with an intensity of 60-80% of one repetitio
Prevention
Intervention group 1: Weight training and supplementation with green tea: 10 subjects did weight training for 8 weeks, 3 sessions per week, with an intensity of 60-80% of one repetition maximum. In ad
Intervention groups 2: Weight training, 10 participants did resistance training for 8 weeks and 3 sessions per week, with an intensity of 60-80% of one repetition maximum.
Control group: 10 subjects did no exercise and supplementation and only had to do routine activities.

Sponsors

Vice Chancellor for research of University of Kurdistan
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 27 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Overweight men with body mass index between 25-30 kg/m2; age range 18-27 years; no history of chronic disease; orthopedic problems; smoking and taking antioxidant supplements. Exclusion criteria: More than three absences during a training session; gastrointestinal discomfort and physical injury.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Cholesterol, TG, HDL and LDL. Timepoint: Before and after intervention. Method of measurement: Cholesterol, triglycerides, HDL and LDL were measured with spectrophotometer method using kits from Pars Azmun company Iran.;Fibrinogen. Timepoint: Before and after intervention. Method of measurement: Fibrinogen concentration was measured with thrombin clotting time method using sigma kit from Kyowl Medex company, Japan.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarhad Ahmadi Kani Golzar

University of Kurdistan

farhadahmadi19@yahoo.com+98 87 1351 4346

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026